TECH (Bio-Techne) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECH Bio-Techne Corp TECH
87 GF Score
Price $72.37
GF Value $71.27
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bio-Techne Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bio-Techne  (NAS:TECH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bio-Techne Cyclically Adjusted PB Ratio Related Terms


Bio-Techne Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Cyclically Adjusted PB Ratio Chart

Bio-Techne Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.25 8.78 7.04 4.71 5.97

Bio-Techne Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.73 5.02 5.26 4.53 5.98

TECH vs SMMT, HALO, ARWR: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Bio-Techne's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Cyclically Adjusted PB Ratio falls into.


TECH
87GF Score
Bio-Techne Corp TECH
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bio-Techne's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bio-Techne's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=13.506/333.9520*333.9520
=13.506

Current CPI (Jun. 2026) = 333.9520.

Bio-Techne Quarterly Data

Book Value per Share CPI Adj_Book
201609 6.001 241.428 8.301
201612 0.000 241.432 0.000
201703 6.080 243.801 8.328
201706 6.355 244.955 8.664
201709 6.414 246.819 8.678
201712 6.657 246.524 9.018
201803 7.047 249.554 9.430
201806 7.173 251.989 9.506
201809 7.337 252.439 9.706
201812 7.264 251.233 9.656
201903 7.578 254.202 9.955
201906 7.682 256.143 10.016
201909 7.708 256.759 10.025
201912 8.642 256.974 11.231
202003 8.468 258.115 10.956
202006 8.980 257.797 11.633
202009 9.322 260.280 11.961
202012 9.873 260.474 12.658
202103 9.960 264.877 12.557
202106 10.084 271.696 12.395
202109 10.484 274.310 12.763
202112 10.825 278.802 12.966
202203 10.909 287.504 12.671
202206 10.859 296.311 12.238
202209 11.159 296.808 12.555
202212 11.631 296.797 13.087
202303 12.010 301.836 13.288
202306 12.475 305.109 13.654
202309 12.616 307.789 13.688
202312 12.495 306.746 13.603
202403 12.785 312.332 13.670
202406 13.076 314.175 13.899
202409 13.461 315.301 14.257
202412 13.162 315.605 13.927
202503 12.873 319.799 13.443
202506 12.382 322.561 12.819
202509 12.622 324.800 12.978
202512 12.901 324.054 13.295
202603 13.323 330.213 13.474
202606 13.506 333.952 13.506

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bio-Techne (TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be overvalued. The current stock price of $72.37 is trading 1.5% above its estimated GF Value™ of $71.27. GuruFocus considers Bio-Techne to be Fairly Valued.

Key valuation signals for TECH:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $71.27 vs. price of $72.37 (1.5% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Other Exchanges TE1:GermanyT1CH34:Brazil
Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
87GF Score

Get the complete analysis for TECH

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.37
Price
$71.27
GF Value